Heart Failure

Showing NaN - NaN of 97

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Heart Failure Trial in United States (Elevated night pacing on, Elevated night pacing off)

Completed
  • Heart Failure
  • Elevated night pacing on
  • Elevated night pacing off
  • Tucson, Arizona
  • +9 more
Apr 16, 2021

Heart Failure Trial in Worldwide (Vericiguat (BAY1021189) (1.25 mg), Vericiguat (BAY1021189) (5 mg), Placebo)

Completed
  • Heart Failure
  • Vericiguat (BAY1021189) (1.25 mg)
  • +2 more
  • Fountain Valley, California
  • +156 more
Mar 2, 2021

Heart Failure Trial in Worldwide (Vericiguat (BAY1021189) (1.25 mg), Vericiguat (BAY1021189) (5 mg), Placebo)

Completed
  • Heart Failure
  • Vericiguat (BAY1021189) (1.25 mg)
  • +2 more
  • Fountain Valley, California
  • +157 more
Feb 25, 2021

Heart Failure, Cardiomyopathy Trial in Kansas City, Nashville (Inhaled nebulized milrinone)

Recruiting
  • Heart Failure
  • Cardiomyopathy
  • Inhaled nebulized milrinone
  • Kansas City, Kansas
  • +1 more
Mar 9, 2021

Heart Failure Trial in Worldwide (Cardiac Resynchronization Therapy - MPP)

Completed
  • Heart Failure
  • Cardiac Resynchronization Therapy - MPP
  • Birmingham, Alabama
  • +77 more
Feb 15, 2021

Model 4396 Left Ventricular (LV) Lead Chronic Performance Study

Completed
  • Heart Failure
    • Gilbert, Arizona
    • +51 more
    Feb 15, 2021

    Heart Failure Trial in United States (Digital Engagement, Direct Engagement)

    Completed
    • Heart Failure
    • Digital Engagement
    • Direct Engagement
    • Birmingham, Alabama
    • +153 more
    Jan 22, 2021

    Heart Failure Trial in Worldwide (HNO Donor, Placebo)

    Completed
    • Heart Failure
    • HNO Donor
    • Placebo
    • Tucson, Arizona
    • +115 more
    Dec 11, 2020

    Proteasome Inhibition

    Completed
    • Heart Failure
    • Multiple Myeloma
      • Philadelphia, Pennsylvania
      • +1 more
      Sep 10, 2020

      Heart Failure, Heart Failure Acute, Acute Cardiac Pulmonary Edema Trial in United States (other, drug, device)

      Completed
      • Heart Failure
      • +3 more
      • LUS-guided strategy-of-care
      • +4 more
      • Indianapolis, Indiana
      • +5 more
      May 19, 2020

      Heart Failure Trial in United States (GUIDED-HF, Standard of Care)

      Completed
      • Heart Failure
      • GUIDED-HF
      • Standard of Care
      • Atlanta, Georgia
      • +14 more
      Apr 17, 2020

      VITROS Immunodiagnostic Products NT-proBNP II

      Completed
      • Heart Failure
      • VITROS Immunodiagnostic Products
      • Montgomery, Alabama
      • +24 more
      Mar 5, 2020

      Heart Failure Trial in Worldwide (Attain Stability Quad Left Ventricular Pacing Lead)

      Completed
      • Heart Failure
      • Attain Stability Quad Left Ventricular Pacing Lead
      • Phoenix, Arizona
      • +49 more
      Dec 19, 2019

      Heart Failure Trial in Nashville (tolvaptan, Chlorothiazide, Metolazone)

      Completed
      • Heart Failure
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Oct 20, 2019

      Heart Failure Trial in Nashville (HF training, No HF training)

      Completed
      • Heart Failure
      • HF training
      • No HF training
      • Nashville, Tennessee
        Tennessee Valley Healthcare System Nashville Campus, Nashville,
      Oct 29, 2019

      Heart Failure Trial in United States (Chronicle Implantable Hemodynamic Monitor, Standard of Care)

      Completed
      • Heart Failure
      • Chronicle Implantable Hemodynamic Monitor
      • Standard of Care
      • Birmingham, Alabama
      • +27 more
      Aug 13, 2019

      Heart Failure, Decompensated Heart Failure, Acute Heart Failure Trial in Worldwide (CXL-1427, Placebo)

      Completed
      • Heart Failure
      • +2 more
      • Gainesville, Florida
      • +34 more
      Jul 29, 2019

      Model 4296 Left Ventricular (LV) Lead Chronic Performance Study

      Completed
      • Heart Failure
        • Birmingham, Alabama
        • +98 more
        Jul 19, 2019

        Heart Failure, Nonischemic Dilated Cardiomyopathy Trial in Nashville (spironolactone)

        Completed
        • Heart Failure
        • Nonischemic Dilated Cardiomyopathy
        • Nashville, Tennessee
          Vanderbilt Heart and Vascular Institute
        May 30, 2019

        Heart Failure, Coronary Artery Disease Trial in Worldwide (Rivaroxaban, Placebo, Standard of care for heart failure and coronary

        Completed
        • Heart Failure
        • Coronary Artery Disease
        • Alexander City, Alabama
        • +577 more
        Apr 18, 2019

        Quadripolar Pacing Post Approval Study

        Completed
        • Heart Failure
        • CRT-D System
        • Birmingham, Alabama
        • +70 more
        Apr 12, 2019

        Quadripolar CRT-D On Currently Approved Lead SystemS

        Completed
        • Heart Failure
          • Gilbert, Arizona
          • +59 more
          Apr 1, 2019

          DF4 Connector System Post-Approval Study

          Completed
          • Ventricular Tachycardia
          • +3 more
            • Birmingham, Alabama
            • +77 more
            Mar 18, 2019

            Heart Failure Trial in United States (CRT-D and LV lead (Quartet™ lead and Promote Q® device system))

            Completed
            • Heart Failure
            • CRT-D and LV lead (Quartet™ lead and Promote Q® device system)
            • Birmingham, Alabama
            • +23 more
            Feb 7, 2019

            Model 4965 Post-Approval Study

            Completed
            • Heart Failure
            • +3 more
              • Birmingham, Alabama
              • +106 more
              Feb 11, 2019